PPA
TXMD icon

Parametric Portfolio Associates’s TherapeuticsMD TXMD Stock Holding History

Parametric Portfolio Associates’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-632
Closed -$42K – 3595
2021
Q1 		$42K Sell
632
-41
-6% -$3.21K ﹤0.01% 4030
2020
Q4 		$41K Sell
673
-119
-15% -$8.13K ﹤0.01% 3956
2020
Q3 		$63K Buy
792
+435
+122% +$34.7K ﹤0.01% 3850
2020
Q2 		$22K Sell
357
-334
-48% -$19.4K ﹤0.01% 3894
2020
Q1 		$37K Sell
691
-1,324
-66% -$131K ﹤0.01% 3863
2019
Q4 		$244K Sell
2,015
-66
-3% -$9.49K ﹤0.01% 3663
2019
Q3 		$378K Buy
2,081
+1,292
+164% +$182K ﹤0.01% 3440
2019
Q2 		$103K Buy
789
+3
+0.4% +$538 ﹤0.01% 3838
2019
Q1 		$191K Buy
786
+51
+7% +$13.5K ﹤0.01% 3727
2018
Q4 		$140K Sell
735
-1,303
-64% -$318K ﹤0.01% 3734
2018
Q3 		$668K Sell
2,038
-113
-5% -$34.6K ﹤0.01% 3301
2018
Q2 		$671K Sell
2,151
-87
-4% -$26.6K ﹤0.01% 3226
2018
Q1 		$545K Buy
2,238
+1,239
+124% +$348K ﹤0.01% 3301
2017
Q4 		$302K Buy
999
+349
+54% +$97.2K ﹤0.01% 3564
2017
Q3 		$172K Buy
650
+134
+26% +$38.7K ﹤0.01% 3889
2017
Q2 		$136K Sell
516
-781
-60% -$196K ﹤0.01% 3891
2017
Q1 		$467K Buy
1,297
+4
+0.3% +$1.24K ﹤0.01% 3225
2016
Q4 		$373K Buy
1,293
+335
+35% +$104K ﹤0.01% 3318
2016
Q3 		$326K Sell
958
-752
-44% -$275K ﹤0.01% 3378
2016
Q2 		$727K Sell
1,710
-181
-10% -$74.6K ﹤0.01% 3016
2016
Q1 		$605K Buy
1,891
+1,280
+209% +$437K ﹤0.01% 3230
2015
Q4 		$317K Buy
+611
New +$226K ﹤0.01% 3530
2015
Q3 		– Sell
-328
Closed -$129K – 3330
2015
Q2 		$129K Buy
+328
New +$116K ﹤0.01% 3841

Other funds holding TXMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Parametric Portfolio Associates's TXMD Position: Q2 2021 in Review

Parametric Portfolio Associates sold out of TherapeuticsMD (TXMD) in Q2 2021, closing a stake of 632 shares — an estimated $42K sold.

Parametric Portfolio Associates first reported a position in TXMD in Q2 2015 and held it in 23 quarters. The position peaked at $727K in Q2 2016. 154 funds tracked by Wall St. Rank hold TXMD as of Q2 2021.

  • Parametric Portfolio Associates reported no remaining TherapeuticsMD position as of Q2 2021 after selling out during the quarter.
  • Parametric Portfolio Associates sold 632 TherapeuticsMD shares in Q2 2021, an estimated $42K.
  • Parametric Portfolio Associates first reported a position in TherapeuticsMD in Q2 2015 and held it in 23 quarters.
  • Parametric Portfolio Associates's TherapeuticsMD position peaked at $727K in Q2 2016.
  • 154 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2021.

Based on Parametric Portfolio Associates's 13F filing for Q2 2021, filed 13 Aug 2021.